Gem Aromatics Reports Q1FY27 Results; Revenue Grows Year-on-Year as Margin Pressures Continue
Gem Aromatics Ltd., a manufacturer of specialty ingredients, essential oils, aroma chemicals, and value-added derivatives, announced its un-audited financial results for the quarter ended June 30, 2026. The company reported revenue growth year-over-year (YoY) in the standalone segment despite facing margin pressures due to raw material costs and higher operating expenses.The consolidated figures showed a decrease in Gross Profit and EBITDA margin compared to Q1FY26.
Standalone Financial Performance Highlights
For the quarter, Gem Aromatics recorded a Revenue from Operations of Rs 83.0 Cr, marking an 8.6% increase compared to Q1FY26 (Rs 76.4 Cr). However, Gross Profit saw a sharp decline of -23.2%, falling to Rs 14.7 Cr from Rs 19.1 Cr in the previous year.The company's EBITDA stood at Rs 8.5 Cr, down from Rs 10.5 Cr in Q1FY26, representing a 19.0% decrease. Profit After Tax (PAT) was reported at Rs 7.3 Cr, showing an 11.0% rise compared to the prior year's Q1.
The financial performance metrics across the standalone segment are detailed below:
| Particulars (Rs Cr) | Q1FY27 | Q1FY26 | Y-o-Y % | Q4FY26 | Q-o-Q % |
|---|---|---|---|---|---|
| Revenue from Operations | 83.0 | 76.4 | 8.6% | 112.2 | -26.1% |
| Gross Profit | 14.7 | 19.1 | -23.2% | 26.2 | -44.0% |
| Gross Margin (%) | 17.7% | 25.0% | -734 bps | 23.4% | -566 bps |
| EBITDA | 8.5 | 10.5 | -19.0% | 15.1 | -43.4% |
| EBITDA Margin (%) | 10.3% | 13.8% | -350 bps | 13.4% | -315 bps |
| PAT | 7.3 | 6.5 | 11.0% | 11.9 | -39.0% |
| PAT Margin (%) | 8.7% | 8.5% | 18 bps | 10.6% | -185 bps |
Consolidated Financial Highlights
Consolidated results showed Revenue from Operations reaching Rs 98.9 Cr, up 12.8% from Q1FY26 (Rs 87.6 Cr). Gross Profit stood at Rs 16.5 Cr, a decline of -36.2% from the prior year's Rs 25.9 Cr. EBITDA was reported at Rs 3.3 Cr, compared to Rs 14.9 Cr in Q1FY26.The consolidated PAT reflected a significant drop, posting a loss of Rs 7.9 Cr against an attributable profit of Rs 8.0 Cr in the previous period.
Consolidated performance data is as follows:
| Particulars (Rs Cr) | Q1FY27 | Q1FY26 | Y-o-Y % | Q4FY26 | Q-o-Q % |
|---|---|---|---|---|---|
| Revenue from Operations | 98.9 | 87.6 | 12.8% | 110.4 | -10.5% |
| Gross Profit | 16.5 | 25.9 | -36.2% | 33.7 | -51.0% |
| Gross Margin (%) | 16.7% | 29.5% | -1282 bps | 30.5% | -1384 bps |
| EBITDA | 3.3 | 14.9 | -77.7% | 15.7 | -79.0% |
| EBITDA Margin (%) | 3.3% | 17.0% | -1361 bps | 14.2% | -1089 bps |
| PAT | -7.9 | 8.0 | -198.6% | 1.0 | -877.3% |
| PAT Margin (%) | -8.0% | 9.1% | -1708 bps | 0.9% | -888 bps |
Operational Updates and Strategic Initiatives
The company noted that revenue growth in Q1FY27 was seasonally softer, with the Clove business facing challenges due to floods in Madagascar, which affected raw material pricing. The situation has since normalized, supporting a more stable operating environment.Gem Aromatics is strategically advancing several product verticals:
- International Market Expansion: The company approved the incorporation of a Wholly Owned Subsidiary in Brazil to boost its distribution capabilities across Latin America for essential oils and specialty chemicals.
- Krystal Ingredients Pvt. Ltd (Wholly Owned Subsidiary): Progress was reported on cooling agents, where customer audits were completed and initial orders secured for GEM Cool 03, GEM Cool 05, and GEM Cool 23. Revenue from this segment is anticipated starting in Q3FY27.
- For Safranal, the process is progressing through customer approvals, with revenue contribution expected toward the end of Q2FY27.
- Regarding Phenol Derivatives, trial production is scheduled for the end of Q2FY27, targeting commercial production and meaningful revenue generation from Q4FY27.
The company attributed margin pressure to both product mix issues and higher raw material costs, alongside increased operating expenses resulting from a newly commissioned facility.
Mr. Yash Vipul Parekh, MD & CEO, commented on the results, stating that while Q1FY27 saw YoY revenue growth in a seasonally softer quarter, the focus is shifting towards monetizing the expanded manufacturing platform at Dahej and scaling up newer product categories through Krystal Ingredients. He noted that innovation remains central to the long-term strategy, and the proposed Brazil subsidiary is expected to enhance Latin American distribution reach.
GEMAROMA Stock Price Movement
On Thursday, shares of Gem Aromatics Limited rallied, settling at ₹174.90 after gaining 2.59% (₹4.41). The equity closed within a trading range of ₹170.6 to ₹177.67 and saw a total volume of 63,126 shares recorded for the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.